MedTrace Logo

Screening Of Adult urBan pOpulation To diAgnose Heart Failure

NCT03526601 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2861

Last updated 2018-05-16

No results posted yet for this study

Summary

Screening Of adult urBan pOpulation To diAgnose Heart Failure (SOBOTA-HF) is a cross-sectional prevalence study in a representative sample of Murska Sobota residents aged 55 years or more. Individuals will be invited to participate in a screening with NT-proBNP. All subjects with NT-proBNP ≥ 125 pg/mL will be invited for a diagnostic visit that will include history and physical examination, electrocardiogram, echocardiography, ankle brachial index, pulmonary function tests, body composition measurement, physical performance tests and questionnaires. To validate the screening procedure, a control group (NT-proBNP \< 125 pg/mL) will undergo same diagnostic evaluation. An external center will validate echodardiography exams and the HF diagnosis will be adjudicated within an independent HF expert panel. Overall and age specific HF prevalence will be calculated in individuals ≥ 55 years and extrapolated to the whole population.

Conditions

Interventions

DIAGNOSTIC_TEST

NT-proBNP, echocardiography

screening

Sponsors & Collaborators

  • Roche Pharma AG

    collaborator INDUSTRY

  • Slovenian Research Agency

    collaborator OTHER

  • Murska Sobota Municipiality

    collaborator UNKNOWN

  • Community Health Center Murska Sobota

    collaborator UNKNOWN

  • General Hospital Murska Sobota

    lead OTHER

Principal Investigators

  • Mitja Lainscak, MD, PhD · General Hospital Murska Sobota

Eligibility

Min Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-05-10
Primary Completion
2018-06-30
Completion
2018-09-30

Countries

  • Slovenia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03526601 on ClinicalTrials.gov